United States · FDA National Drug Code directory
Budesonide Inhalation
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0115-1689_dbb6c949-66b1-4f60-ab96-442dd8b4ea19
- Product NDC
- 0115-1689
- Form
- SUSPENSION
- Composition / generic term
- Budesonide
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160804
- Source listing expiry
- 20271231
Source-listed ingredients
- BUDESONIDE — .5 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 6 POUCH in 1 CARTON (0115-1689-74) / 5 VIAL in 1 POUCH (0115-1689-76) / 2 mL in 1 VIAL · 0115-1689-74
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →